Please login to the form below

Not currently logged in
Email:
Password:

Zantac

This page shows the latest Zantac news and features for those working in and with pharma, biotech and healthcare.

GSK and Apotex join generic Zantac recalls as carcinogen concerns mount

GSK and Apotex join generic Zantac recalls as carcinogen concerns mount

Now GlaxoSmithKline, the original branded manufacturer of Zantac, has stopped global distribution of the medicine, and will recall the drug in India and Hong Kong. ... Reddy’s has an FDA-approval to sell its own versions of prescription and OTC generic

Latest news

  • Distribution of Novartis’ generic Zantac halted due to carcinogen concerns Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

    Other versions of Zantac have also been recalled in Europe and Canada as well. ... Sandoz is only one of various drug manufacturers that distribute these medicines, with Sanofi making branded Zantac sold over-the-counter.

  • Perrigo expands consumer health with €3.6bn Omega purchase Perrigo expands consumer health with €3.6bn Omega purchase

    Belgium-based Omega has also expanded in recent years purchasing several over-the-counter (OTC) medicines from GlaxoSmithKline (GSK) in 2012, including Lactacyd, Abtei, Solpadeine, Zantac, Nytol and Beconase.

  • GSK plans to sell off older products GSK plans to sell off older products

    Imitrex (sumatriptan) for migraine, the antidepressant Paxil/Seroxat (paroxetine) and gastrointestinal therapy Zantac (ranitidine) have all been named in dispatches as former blockbuster brands that are now in GSK's 'established

  • Boehringer creates ‘Captain Zantac’ Boehringer creates ‘Captain Zantac

    This is an exciting new chapter in the evolution of the Zantac brand," said Ross Ullman, executive director of marketing, Boehringer Ingelheim Consumer Healthcare. . ... Zantac has been a leader in heartburn relief for more than two decades.

  • GSK sells Lucozade and Ribena for £1.35bn GSK sells Lucozade and Ribena for £1.35bn

    This was followed in March 2012 by the sale to Belgian company Omega of brands such as Lactacyd, Abtei, Solpadeine, Zantac, Nytol and Beconase for £391m and then a month later

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    It was also the dawn of the industry's blockbuster era, which for Glaxo meant the years of its star-performing indigestion and heartburn treatment Zantac.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics